BY ALLERGIC LIVING When the U.S. Food and Drug Administration (FDA) approved a new oral immunotherapy (OIT) for peanut allergy… Read more »
Search Results for: OIT
Europe’s Palforizia OIT Study Shows Speed of Desensitization
Phase 3 results from the European clinical trial of the Palforzia peanut OIT treatment show that desensitization to the allergenic… Read more »
Palforzia OIT Study Sees Maturing of Immune System Over Time
A new study finds encouraging results for those considering the first FDA-approved peanut allergy immunotherapy. It reveals that clinical trial… Read more »
FDA Approves Aimmune’s Palforzia OIT, Coming Soon to Allergist Clinics
The Food and Drug Administration on Jan. 31 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy in… Read more »
Panel Backs FDA Approval for Aimmune’s Peanut OIT Drug
An expert advisory panel has recommended that the Food and Drug Administration approve Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for… Read more »
FARE’s Chief Medical Advisor on Why Standardizing OIT is Needed Now
A Q&A with FARE about the consensus the non-profit hopes to achieve at a fall summit on OIT.
Study Favoring Avoidance Over Food Allergy OIT Ignites Controversy
A systematic review of peanut oral immunotherapy that compared 12 controlled studies has brought a longstanding “pro or con” debate… Read more »
FDA Launches Its Review of AR101 Peanut OIT Drug
The FDA is now officially reviewing the biologics license application (BLA) for AR101, the peanut oral immunotherapy drug that underwent… Read more »
Boiled Peanut Safe and Effective to Use During OIT, Study Finds
Using boiled peanut protein in oral immunotherapy treatment (OIT) is safe and effective, with fewer gastrointestinal symptoms compared to using… Read more »
Long-Term Peanut OIT Has Lasting Benefits, Study Reveals
In a long-term follow-up with 55 peanut-allergic children who had undergone oral or sublingual immunotherapy, 89 percent of patients followed… Read more »